Cargando…
Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 Helicase
The raging COVID-19 pandemic caused by SARS-CoV2 has infected millions of people and killed several hundred thousand patients worldwide. Currently, there are no effective drugs or vaccines available for treating coronavirus infections. In this study, we have focused on the SARS-CoV2 helicase (Nsp13)...
Autores principales: | White, Mark Andrew, Lin, Wei, Cheng, Xiaodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430582/ https://www.ncbi.nlm.nih.gov/pubmed/32817950 http://dx.doi.org/10.1101/2020.08.09.243246 |
Ejemplares similares
-
An immunoinformatics approach to study the epitopes of SARS-CoV-2 helicase, Nsp13
por: Kumar, Sushant, et al.
Publicado: (2023) -
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase
por: Zeng, Jingkun, et al.
Publicado: (2021) -
Punicalagin as an allosteric NSP13 helicase inhibitor potently suppresses SARS-CoV-2 replication in vitro
por: Lu, Lian, et al.
Publicado: (2022) -
Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase
por: Newman, Joseph A., et al.
Publicado: (2021) -
Force-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase
por: Mickolajczyk, Keith J., et al.
Publicado: (2021)